Methods of using thalidomide in combination with irinotecan
US7479499B2 · kind B2 · utility
6Cited by
7References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 11, 2005 |
| Grant date | Jan 20, 2009 |
| Priority date | — |
| Expiry date | Jan 26, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to compositions comprising thalidomide and irinotecan, which can be used in the treatment or prevention of colorectal cancer. The invention also relates to methods of treating or preventing colorectal cancer which comprise the administration of thalidomide and irinotecan to a patient in need of such treatment or prevention. The invention further relates to methods of reducing or avoiding adverse side effects associated with the administration of irinotecan which comprise the administration of thalidomide to a patient in need of such reduction or avoidance.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.